Comment on: Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real-life ELU study

doi:10.18240/ijo.2021.07.26

Home > Archive>Volume 14, Issue 7, 2021 >1127-1128. DOI:10.18240/ijo.2021.07.26

Comment on: Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real-life ELU study
DOI:
                        10.18240/ijo.2021.07.26
                    
Author:
                        
                        
                    
Corresponding Author:Mihai C?lug?ru. Department of Ophthalmology, University of Medicine, Strada Brancoveanu 11, Cluj-Napoca 400467, Romania. profesor.mihai.calugaru@gmail.com
Affiliation:
Clc Number:
Fund Project:

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Abstract:

Reference

Cited by

Get Citation

Dan Calugaru, Mihai Calugaru. Comment on: Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real-life ELU study. Int J Ophthalmol, 2021,14(7):1127-1128

Copy

Article Metrics

Abstract:
PDF:
HTML:
Cited by:

Publication History

Received:June 28,2020
Revised:February 22,2021
Adopted:
Online: May 25,2021
Published:

Home

Articles

Journal Info

For Authors

For Reviewers

Publication Policies

News and Events

RSS

Get Citation

Share

Article Metrics

Publication History